Attached files
| file | filename |
|---|---|
| EX-10.179 - CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT - VG Life Sciences Inc. | vglife_10q-ex10179.htm |
| EX-10.180 - CONVERTIBLE PROMISSORY NOTE - VG Life Sciences Inc. | vglife_10q-ex10180.htm |
| EX-4.9 - WARRANTS - VG Life Sciences Inc. | vglife_10q-ex0409.htm |
| EX-31.2 - CERTIFICATION - VG Life Sciences Inc. | vglife_10q-ex3102.htm |
| EX-10.178 - CONSULTING AGREEMENT - VG Life Sciences Inc. | vglife_10q-ex10178.htm |
| 10-Q - FORM 10-Q - VG Life Sciences Inc. | vglife_10q-063015.htm |
| EX-31.1 - CERTIFICATION - VG Life Sciences Inc. | vglife_10q-ex3101.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officers of VG Life Sciences Inc., a Delaware corporation (the “Company”), do hereby certify, to such officers’ knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: August 19, 2015 | By: | /s/ John Tynan | |
|
John Tynan Chief Executive Officer (Principal Executive Officer) |
|||
| Date: August 19, 2015 | By: | /s/ David Odell | |
|
David Odell Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | |||